Vote Scores
Filings read through

CSPC Pharmaceutical Group Limited: how funds voted at the meeting of 28 May 2026

Meeting
Season
year to 30 June 2026
Filers reporting
86
Ballot items
7

86 filers on Form N-PX reported votes at the CSPC Pharmaceutical Group Limited meeting of 28 May 2026. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    10 nominees. 90.8% of the reported votes are for. 38 filers withheld from or voted against at least one nominee.

    1,362 vote records from 85 filers. 1 of the 84 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 30 fund families
    • For 30
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1 vote record from 1 filer. 0 of the 1 filer that marked the item voted against management.

  3. Item 3: Audit-related items (auditor ratification)

    134 vote records from 83 filers. 53 of the 82 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 30 fund families
    • For 9
    • Against 21
    • Against management 19
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    408 vote records from 85 filers. 0 of the 84 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 30 fund families
    • For 30
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    272 vote records from 85 filers. 1 of the 84 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 30 fund families
    • For 6
    • Against 1
    • Split or no vote 23
    • Against management 1
  6. Item 6: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    257 vote records from 85 filers. 2 of the 84 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 30 fund families
    • For 27
    • Split or no vote 3
  7. Item 7: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    41 vote records from 14 filers. 0 of the 13 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 2 fund families
    • For 2

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at CSPC Pharmaceutical Group Limited, meeting of 28 May 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family3. Auditor
American CenturyAgainst, against management
BlackRock and iSharesFor
BNY MellonAgainst, against management
Brighthouse FundsAgainst
Charles SchwabFor
DimensionalAgainst, against management
EquitableAgainst, against management
FidelityAgainst, against management
Franklin TempletonAgainst, against management
Goldman SachsAgainst, against management
Hartford FundsFor
InvescoAgainst, against management
J.P. MorganAgainst, against management
Jackson National fundsAgainst, against management
John Hancock and ManulifeAgainst, against management
Lincoln FinancialAgainst
MFSFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against management
Northern Trust and FlexSharesAgainst, against management
Nuveen and TIAAFor
Pacific Life fundsAgainst, against management
PIMCOAgainst, against management
Russell InvestmentsFor
State Street and SPDRAgainst, against management
T. Rowe PriceFor
ThriventAgainst, against management
VanguardFor
Victory CapitalAgainst, against management
VoyaFor
WisdomTreeAgainst, against management

Questions

How many filers reported votes at the CSPC Pharmaceutical Group Limited meeting?
86 Form N-PX filers reported votes at the meeting of 28 May 2026. On say-on-pay, 0 of 1 filers that marked the item voted against management (0.0%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. CSPC Pharmaceutical Group Limited reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list CSPC Pharmaceutical Group Limited with a meeting date within three days of 28 May 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .